XML 14 R2.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Interim Consolidated Balance Sheets (Unaudited) - USD ($)
Jun. 30, 2024
Dec. 31, 2023
Current assets    
Cash and cash equivalents $ 1,018,862 $ 1,404,160
Restricted cash 175,321 90,413
Prepaid expenses and other current assets 319,796 366,316
Total current assets 1,513,979 1,918,439
Other assets 114,286
Equipment, net 1,247 1,721
Intangible assets, net 452,490 532,010
Total assets 2,082,002 2,452,170
Current liabilities    
Accounts payable and accrued liabilities 1,242,237 1,394,117
Deferred income 28,898 10,413
Total current liabilities 1,571,135 2,615,993
Warrant liability 946,105 4,455,747
Other long-term liabilities 46,765 84,125
Total liabilities 3,475,468 7,155,865
Stockholders’ deficiency    
Common shares, no par value, unlimited shares authorized, 150,505,536 and 118,208,989 shares issued and outstanding as of June 30, 2024, and December 31, 2023 49,009,464 39,760,287
Class B preferred shares, $0.25 par value, unlimited shares authorized, 7,916,380 shares issued and outstanding as of June 30, 2024, and December 31, 2023 62 62
Additional paid-in capital 18,467,705 17,288,430
Accumulated other comprehensive loss (104,301) (104,301)
Accumulated deficit (68,766,396) (61,648,173)
Total stockholders’ deficiency (1,393,466) (4,703,695)
Total liabilities and stockholders’ deficiency 2,082,002 2,452,170
Related Party    
Current assets    
Related party note receivable, net 57,550
Current liabilities    
Accounts payable and accrued liabilities 1,242,237 1,394,117
Current portion of promissory note - related party 300,000 1,211,463
Promissory note – related party $ 911,463